英特格拉生命科学

最新新闻

• 评级变动
  Argus Research Upgrades Integra Lifesciences(IART.US) to Buy Rating, Announces Target Price $25
  \u5e02\u573a\u8d44\u8baf · 2026/6/18
• Truist Financial Maintains Integra Lifesciences(IART.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• Citi Maintains Integra Lifesciences(IART.US) With Hold Rating, Maintains Target Price $19
  \u5e02\u573a\u8d44\u8baf · 2026/8/13
• 评级变动
  Citi Maintains Integra Lifesciences(IART.US) With Sell Rating, Cuts Target Price to $9
  \u5e02\u573a\u8d44\u8baf · 2026/3/11
• 评级变动
  Truist Financial Maintains Integra Lifesciences(IART.US) With Hold Rating, Raises Target Price to $19
  \u5e02\u573a\u8d44\u8baf · 2026/7/16
• BTIG Maintains Integra Lifesciences(IART.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/10/3
• 评级变动
  Argus Research Downgrades Integra Lifesciences(IART.US) to Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/4/15
• Citi Maintains Integra Lifesciences(IART.US) With Hold Rating, Cuts Target Price to $15
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• 评级变动
  Wells Fargo Maintains Integra Lifesciences(IART.US) With Hold Rating, Raises Target Price to $15
  \u5e02\u573a\u8d44\u8baf · 2026/5/6
• 评级变动
  Citi Upgrades Integra Lifesciences(IART.US) to Hold Rating, Raises Target Price to $16
  \u5e02\u573a\u8d44\u8baf · 2026/5/28
• 评级变动
  Citi Maintains Integra Lifesciences(IART.US) With Sell Rating, Raises Target Price to $11
  \u5e02\u573a\u8d44\u8baf · 2026/5/6
• 评级变动
  BofA Securities Initiates Integra Lifesciences(IART.US) With Sell Rating
  \u5e02\u573a\u8d44\u8baf · 2026/5/14
• 评级变动
  BMO Capital Maintains Integra Lifesciences(IART.US) With Hold Rating, Announces Target Price $19
  \u5e02\u573a\u8d44\u8baf · 2026/7/10
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Kairos Pharma, Ltd. (KAPA), Integra Lifesciences (IART) and Biogen (BIIB)
  TipRanks · 2026/5/14
• 评级变动
  BMO Capital Maintains Integra Lifesciences(IART.US) With Hold Rating, Cuts Target Price to $18
  \u5e02\u573a\u8d44\u8baf · 2026/7/30
• 评级变动
  Citi Maintains Integra Lifesciences(IART.US) With Sell Rating, Maintains Target Price $9
  \u5e02\u573a\u8d44\u8baf · 2026/4/7
• 评级变动
  Wells Fargo Maintains Integra Lifesciences(IART.US) With Hold Rating, Raises Target Price to $18
  \u5e02\u573a\u8d44\u8baf · 2026/7/30
• 评级变动
  Wells Fargo Downgrades Integra Lifesciences(IART.US) to Hold Rating, Cuts Target Price to $12
  \u5e02\u573a\u8d44\u8baf · 2026/3/18
• 评级变动
  Truist Financial Maintains Integra Lifesciences(IART.US) With Hold Rating, Cuts Target Price to $12
  \u5e02\u573a\u8d44\u8baf · 2026/4/15
• J.P. Morgan Maintains Integra Lifesciences(IART.US) With Sell Rating, Raises Target Price to $17
  \u5e02\u573a\u8d44\u8baf · 2026/8/5

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。